Skip to main content

Fisher Scientific Inks Supply Deal with Mass Bio Council

NEW YORK (GenomeWeb News) – The Massachusetts Biotechnology Council has inked a five-year deal with Fisher Scientific to be the primary supplier for the MBC Purchasing Consortium.

The supply deal is worth up to $250 million over the life of the contract to Fisher, which is part of Waltham, Mass.-based Thermo Fisher Scientific. The council includes around 600 biotech members, which will receive preferred pricing on scientific, safety, and lab products, as well as other incentives.

Robert Coughlin, president and CEO of the council, said in a statement that the Fisher's "extensive portfolio of technologies, lab supply products, and services will provide the quality and savings we demand for our members."

Fisher Scientific takes over the role of primary supplier from VWR International.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.